ARTA
CORV

A.R.T. Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

A.R.T. Advisors’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,803
Closed -$30K – 1903
2019
Q3 		$30K Buy
+14,803
New +$30K ﹤0.01% 1354
2018
Q1 		– Sell
-34,872
Closed -$54K – 1886
2017
Q4 		$54K Buy
34,872
+18,154
+109% +$29.2K ﹤0.01% 1292
2017
Q3 		$35K Buy
+16,718
New +$56.9K ﹤0.01% 1275
2016
Q3 		– Sell
-13,672
Closed -$70K – 1375
2016
Q2 		$70K Buy
+13,672
New +$65.7K ﹤0.01% 1243

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

A.R.T. Advisors's CORV Position: Q4 2019 in Review

A.R.T. Advisors sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 14,803 shares — an estimated $30K sold.

A.R.T. Advisors first reported a position in CORV in Q2 2016 and held it in 4 quarters. The position peaked at $70K in Q2 2016. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • A.R.T. Advisors reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 14,803 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $30K.
  • A.R.T. Advisors first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2016 and held it in 4 quarters.
  • A.R.T. Advisors's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $70K in Q2 2016.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.